Peer-reviewed veterinary case report
Intensive blood sugar control with detemir insulin in diabetic cats
By Roomp, Kirsten & Rand, Jacquie·Published in Journal of feline medicine and surgery·2012·University of Luxembourg·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
- Species:
- cat
Plain-English summary
Eighteen diabetic cats were treated with a new insulin called detemir to help control their blood sugar levels. Owners monitored their cats' glucose at home, and the results were promising, with about 67% of the cats going into remission from diabetes. Cats that started treatment within six months of diagnosis had even better results, with an 81% remission rate. Overall, detemir showed similar effectiveness to another insulin called glargine, making it a viable option for managing diabetes in cats.
People also search for: diabetic cat treatment · insulin for cats · cat diabetes remission rates
Abstract
The aim of this study was to report outcomes using detemir and a protocol aimed at intensive blood glucose control with home monitoring in diabetic cats, and to compare the results with a previous study using the same protocol with glargine. Eighteen cats diagnosed with diabetes and previously treated with other insulins were included in the study. Data was provided by owners who joined the online German Diabetes-Katzen Forum. The overall remission rate was 67%. For cats that began the protocol before or after 6 months of diagnosis, remission rates were 81% and 42%, respectively (P = 0.14). No significant differences were identified between the outcomes for the glargine and detemir studies, with the exception of three possibly interrelated factors: a slightly older median age of the detemir cohort at diabetes diagnosis, a higher rate of chronic renal disease in the detemir cohort and lower maximal dose for insulin detemir.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22553309/